39 Aberrant lipid metabolism promotes the development of skeletal muscle insulin resistance, but 40 the exact identity of lipid-mediated mechanisms relevant to human obesity remains unclear. A 41 comprehensive lipidomic analyses of primary myocytes from lean insulin-sensitive (LN) and 42 obese insulin-resistant (OB) individuals revealed several species of lysophospholipids (lyso-PL) 43 that were differentially-abundant. These changes coincided with greater expression of 44 lysophosphatidylcholine acyltransferase 3 (LPCAT3), an enzyme involved in phospholipid 45 transacylation (Lands cycle). Strikingly, mice with skeletal muscle-specific knockout of LPCAT3 46 (LPCAT3-MKO) exhibited greater muscle lyso-PC/PC, concomitant with greater insulin 47 sensitivity in vivo and insulin-stimulated skeletal muscle glucose uptake ex vivo. Absence of 48 LPCAT3 reduced phospholipid packing of the cellular membranes and increased plasma 49
Introduction 54
Type 2 diabetes is the 7 th leading cause of death in the United States (1) and is a major risk 55 factor for cardiovascular disease, the leading cause of death (2). Skeletal muscle is the site of 56 the largest glucose disposal in humans (3, 4) . Insulin resistance in skeletal muscle is a 57 necessary precursor to type 2 diabetes (5) and can be triggered by aberrant lipid metabolism (6-58 8) . Several classes of lipids have been implicated in initiating cellular signals that suppress 59 insulin action, but there has not been a clear consensus that these molecules are upregulated in 60 skeletal muscle insulin resistance that occurs in the human population (9) (10) (11) (12) (13) (14) . 61 62 A difficulty in accurately measuring the muscle lipidome is confounded by the intramyofibrillar 63 adipocytes which are particularly abundant in muscle biopsy samples from obese humans. 64
Human skeletal muscle cells (HSkMC) are primary myoblasts that can be isolated, propagated, 65 and differentiated from muscle biopsies. This in vitro system provides a unique model to study 66 the skeletal muscle lipidome and signaling pathways free of contaminating cell types and 67 circulating factors that affect muscle metabolism. Importantly, these HSkMC are known to retain 68 their insulin sensitivity phenotype ex vivo, providing a platform to study mechanisms directly 69 relevant to human physiology (15, 16) . 70
71
In this study, we harvested HSkMC from lean insulin-sensitive (LN) and obese insulin-resistant 72 (OB) subjects (Subject Characteristics: Table S1 ). We then propagated and differentiated these 73 samples for analyses of the muscle lipidome, gene expression profile, insulin signaling, and 74 membrane properties ( Figure 1A ). This approach led us to examine the lysophospholipid (lyso-75 PL) remodeling pathway (Lands cycle) as a potential diet-responsive mechanism that regulates 76 skeletal muscle insulin action. Below we provide evidence that implicates this pathway in the 77 pathogenesis of diet-induced skeletal muscle insulin resistance. Genetic or pharmacologic 78 suppression of this pathway was sufficient to enhance skeletal muscle insulin action in vitro and 79 in vivo. 80 81
Results

82
A global lipidomic analysis of LN and OB myotubes revealed many classes of lipids that were 83 differentially abundant ( Figure 1B , Figure S1A -L). Among these, several species of 84 lysophospholipids (lyso-PL), intermediates of the Lands cycle (17), were lower in OB HSkMC 85 compared to LN ( Figure 1C ), a finding not previously described for an insulin-resistant state. 86
While species of many classes of lyso-PL were reduced with obesity, the ratio of lyso-PL to its 87 parent phospholipid were significantly lower for only lysophosphatidylcholine (lyso-88 PC)/phosphatidylcholine (PC) ( Figure 1D ). Previous studies suggest that altering the lyso-PC 89 content of cell membranes is sufficient to alter the physical properties of membranes (18, 19) . 90
Consistent with this notion, phospholipid packing of LN and OB myotubes were remarkably 91 different, with OB cells exhibiting more tightly packed membrane head groups compared to LN 92 ( Figure 1E&F ). This occurred in the absence of changes in the phospholipid acyl-chain 93 saturation index ( Figure S1M) . 94 95 What is the molecular mechanism by which obesity promotes a lower abundance of lyso-PL in 96 skeletal muscle? LN and OB HSkMC utilized for the lipidomic analyses were cultured ex vivo for 97 several weeks in identical media conditions. Thus, differences in the lipidome of these samples 98 are likely the result of genetic and/or epigenetic influences, instead of hormonal or neuronal 99 inputs that alter cells in vivo. We reasoned that such differential programming might be 100 expected to manifest in gene expression profiles. A whole transcriptome sequencing of LN and 101 OB myotubes revealed that lyso-PC acyltransferase 3 (LPCAT3), an enzyme of the Lands 102 cycle, was more highly expressed with obesity. These findings were recapitulated in muscle 103 biopsy samples (not myotubes) from LN and OB individuals as well as muscle tissue from wild-104 type and db/db mice ( Figure 1G ). The Lands cycle represents a series of phospholipid-105 remodeling reactions by which acyl-chains become transacylated (17). Of the thirteen lyso-PL 106 acyltransferase enzymes (20), LPCAT3 has the highest affinity for 16:0 and 18:0 lyso-PC, 107 consistent with the specificity of reduced lyso-PC/PC (21, 22) . Silencing of LPCAT3 in 108 fibroblasts has been shown to increase Akt phosphorylation (23), while incubation of the same 109 cells with 16:0/20:4 PC decreased Akt phosphorylation due to plasma-membrane specific 110 effects (24). Mice with a liver-specific deletion of LPCAT3 exhibit enhanced ordering of 111 membranes (25). In both human and mouse skeletal muscle, LPCAT3 is very highly expressed 112 compared to other isoforms of LPCAT ( Figure 1H ), and skeletal muscle LPCAT3 expression is 113 directly correlated to circulating insulin in 106 mouse strains (data not shown, bicor=0.296, 114 P=0.0016) (26). 115
116
To study the role of LPCAT3 on skeletal muscle insulin action, we performed a lentivirus-117 mediated shRNA knockdown of LPCAT3 (Scrambled, SC; LPCAT3 knockdown, KD) in C2C12 118 myotubes ( Figure 2A ). LPCAT3 knockdown did not affect protein content for MyoD, various 119 MHC isoforms, and respiratory complexes ( Figure S2A -C), suggesting that the deletion of 120 LPCAT3 has no effect on myotube lineage or mitochondrial density. Targeted lipidomic 121 analyses revealed that LPCAT3 knockdown increased lyso-PC and decreased PC ( Figure  122 2B&C), substrates and products of the LPCAT3-mediated reaction, respectively (27, 28) . 123
Together, these differences were sufficient to elevate lyso-PC/PC with LPCAT3 deletion ( Figure S2G ). Analogous to differences observed in LN and OB HSkMC, LPCAT3 deletion 127 reduced phospholipid head group packing ( Figure 2E&F ). We then incubated SC and KD cells 128 in a submaximal concentration of insulin to assess insulin signaling events. Strikingly, inhibition 129 of LPCAT3 robustly enhanced insulin signaling with or without insulin ( Figure 2G , Figure S2H ). 130 promoted enhanced insulin signaling at the level of IR phosphorylation, we visualized the 140 organization of plasma membrane microdomains with labeling and patching of plasma 141 membrane GM-1, a known marker of microdomains. Indeed, a greater proportion of C2C12 142 cells with LPCAT3 knockdown exhibited clustering of GM-1 enriched microdomains ( Figure 2I , 143 top &J). Furthermore, LPCAT3 deletion decreased the size of these clusters ( Figure 2I , bottom 144 &K), with no differences in total fluorescence from each cell ( Figure S2I ). These data indicate 145 that LPCAT3 inhibition induces a reorganization of plasma membrane microdomains, potentially 146 explaining increased IR phosphorylation. 147 148 Next, we examined whether inhibition of muscle LPCAT3 would promote greater insulin 149 sensitivity in vivo. Mice with tamoxifen-inducible skeletal muscle-specific knock-out of LPCAT3 150 (LPCAT3-MKO) were generated by crossing the HSA-MerCreMer mice (34) with LPCAT3 151 conditional knock-out mice (exon3 of the Lpcat3 gene flanked with loxP sites) (25) ( Figure 3A) . 152
This strategy successfully yielded mice with suppressed LPCAT3 expression in skeletal muscle 153 without affecting other tissues ( Figure 3B ), and without compensatory upregulation of other 154 members of the LPCAT family ( Figure 3C ). Control and LPCAT3-MKO mice gained weight 155 equally when fed a high-fat diet (HFD, Figure 3D ) with no difference in adipose tissue weight at 156 the end of diet intervention ( Figure 3E ). Food consumption, whole-body oxygen consumption, 157 spontaneous activity, and respiratory exchange ratio were similarly not different between groups 158 ( Figure 3F -I). Fasting glucose, insulin, and glucose tolerance ( Figure 3J -L) were unchanged, but 159 circulating insulin during the glucose tolerance test was substantially lower in LPCAT3-MKO 160 mice compared to the control group ( Figure 3M) . 161
162
To evaluate whether improved glycemic efficiency was attributable to greater skeletal muscle 163 insulin sensitivity, we quantified insulin-stimulated skeletal muscle glucose uptake ex vivo. 164
Isolated muscles from HFD-fed control and LPCAT3-MKO mice were incubated with or without 165 a submaximal concentration of insulin for the measurement of 2-deoxy-glucose uptake. Indeed, 166
insulin-stimulated skeletal muscle glucose uptake was robustly enhanced in LPCAT3-MKO mice 167 compared to control ( Figure 4A ). The increase in glucose uptake coincided with augmented 168 insulin-stimulated Akt phosphorylation ( Figure 4B&C ), similar to C2C12 and human primary 169 myotubes ( Figure 2 ). These results suggest that inhibition of muscle LPCAT3 increases skeletal 170 muscle insulin sensitivity in vivo. Similar to results from LPCAT3 knockdown in vitro, muscles 171 from LPCAT3-MKO mice had elevated lyso-PC (16:0 and 18:0) ( Figure 4D ) and lower levels of 172 PC species known to be the main products of the LPCAT3 reaction (16:0/18:2 and 16:0/22:4) 173 ( Figure 4E ) (22, 35, 36) . As a result, lyso-PC/PC was ~2-fold greater in LPCAT3-MKO mice 174 compared to control ( Figure 4F ). In contrast, lyso-PE/PE or phospholipid saturation index was 175 unaltered between control and LPCAT3-MKO muscles ( Figure S3A -D), similar to the lipidome in 176 LN and OB HSkMC ( Figure 1&S1 ). Muscles from control and LPCAT3-MKO did not differ in 177 mass, length, force-generating capacity, fiber-type distribution, or content of proteins in the 178 electron transport chain ( Figure 4G -L, Figure S3E -G). 179
180
How does the inhibition of the Lands cycle promote greater insulin action in skeletal muscle? 181 LPCAT3 deficiency enhanced insulin signaling at the level of IR which was concomitant with 182 altered plasma membrane lipid organization ( Figure 2 ), suggesting that changes in plasma 183 membrane properties may mediate the insulin-sensitizing effects. Membrane organization is 184 vital to insulin action, as IR is localized to highly ordered microdomains on the plasma 185 membrane (37, 38). The interaction between caveolae and IR enhances insulin signaling in 186 other cell types (39, 40) . Mice that lack caveolin-3 (cav3), a skeletal muscle-specific scaffolding 187 protein critical in the formation of caveolae on the plasma membrane, exhibit skeletal muscle 188 insulin resistance due to plasma membrane-specific effects on the IR (41, 42). Overexpression 189 of dominant-negative cav3 leads to decreased glucose uptake and glycogen synthesis in 190 C2C12 cells, which is attributed to decreased Akt phosphorylation (43-45). Conversely, an 191 increase in wildtype cav3 expression is sufficient to enhance Akt phosphorylation and glucose 192 uptake (46). Indeed, LPCAT3 knockdown substantially increased cav3 content in C2C12 193 myotubes ( Figure 5A ). To examine the possibility that the absence of LPCAT3 increases the 194 abundance of lipids in caveolae, we isolated membrane fractions from C2C12 myotubes with or 195 without LPCAT3 deletion and subjected them for further purification by density-gradient 196 ultracentrifugation. 197 198 Cholesterol and sphingomyelin are two classes of lipids that are more highly abundant in the 199 detergent-resistant membrane (DRM; i.e. ordered membrane) fraction compared to the 200 detergent-soluble membrane (DSM) fraction (47). Experiments in wild-type C2C12 myotubes 201 indicated that fractions 4-5 have substantial amounts of total lipid ( Figure S5A ). These fractions 202 were enriched in sphingomyelin and cholesterol which are known to be conducive for more 203 highly ordered membrane ( Figure S5B&C ), with relatively low abundance of lipids involved in 204 the LPCAT3-mediated reaction ( Figure S5D -G). LPCAT3 knockdown did not appear to alter the 205 overall content of lipid in the DRM fraction, nor did it affect enrichment of sphingomyelin and 206 cholesterol ( Figure 5B&C ). Even though the DRM fraction is known to contain very little protein 207 (48), we detected substantial cav3 in both SC and KD myotubes ( Figure 5D ). While LPCAT3 208 deletion did not affect the proportion of cav3 in the DRM fraction, it is noteworthy that elevated 209 cav3 content with LPCAT3 knockdown ( Figure 5A ) is reflected in the DRM fraction. This is 210 particularly interesting considering there was no enrichment of sphingomyelin or cholesterol in 211 the DRM fraction, which may have been expected given that these lipids induce sequestration 212 of cav3 into caveolae. Consistent with this notion, LPCAT3 deletion was sufficient to elevate 213 lyso-PC in the DRM as well as DRM fractions of the membrane ( Figure 5E fractions, which may also contribute to the increase in the plasma membrane lipid clustering 217 ( Figure S5D ). Thus, LPCAT3 deletion promotes the accumulation of lyso-PC in the DRM 218 fraction which may contribute to membrane organization. To test our hypothesis that an 219 increase in membrane organization mediates the insulin-sensitizing effect of LPCAT3 deletion, 220
we incubated C2C12 myotubes with methyl-beta-cyclodextrin (MβCD), a cholesterol-depleting 221 compound that disrupts plasma membrane microdomains (49). Indeed, incubation of cells with 222
MβCD decreased cav3 protein content ( Figure 5F ) without decreasing the abundance of flotillin-223 1 ( Figure 5G ), a protein associated with non-caveolar microdomains. MβCD treatment 224 normalized insulin-stimulated Akt phosphorylation with LPCAT3 deletion to control levels ( Figure  225 5H). These findings are consistent with the notion that LPCAT3 deletion enhances IR signaling 226 by its effect on plasma membrane organization. 227 228 CI-976 is a pan lysophospholipid acyltransferase inhibitor (32, 33) that has the ability to disrupt 229
Lands cycle, similar to LPCAT3 deletion. To examine a possibility that the insulin-sensitizing 230 effect of LPCAT3 knockdown is attributable to an unknown function of LPCAT3 outside of the 231 Lands cycle, we studied C2C12 myotubes with or without CI-976. Consistent with our findings 232 with LPCAT3 knockdown ( Figure 2E&F ), pre-incubation of wild-type C2C12 myotubes with CI-233 976 robustly decreased phospholipid headgroup packing ( Figure 5I ). Strikingly, CI-976 also 234 promoted an increase in insulin-stimulated Akt phosphorylation compared to vehicle control 235 ( Figure 5J ). These evidence support our findings that inhibition of Lands cycle alter plasma 236 membrane property to increase skeletal muscle insulin sensitivity. 237 238
Discussion 239
Obesity promotes aberrant lipid metabolism in various tissues including skeletal muscle where it 240 dampens its ability to respond to circulating insulin and increase glucose uptake. Studies in 241 model organisms have led to the identification of lipotoxic lipids that might promote insulin 242 resistance in various tissues (50, 51), but some studies were unable to validate these 243 mechanisms in human muscles (52, 53) . To gain a global understanding of changes that occur 244 in muscle lipid metabolism with human obesity, we conducted lipidomic analyses on muscle 245 samples from LN and OB subjects. Obesity was associated with decreases in various species of 246 lysophospholipids, an observation that had never been previously reported. Many of these lipids 247 are generated by the enzymes of the Lands cycle, which removes fatty-acyl chains at the sn-2 248 position of phospholipids to generate lysophospholipids (Lands cycle). We propose a novel 249 mechanism by which obesity accelerates the skeletal muscle Lands cycle to promote insulin 250 resistance. 251
252
The acceleration of muscle phospholipid transacylation was apparently driven by increased 253 LPCAT3 expression, likely attributable to diet-induced activation of LXRs and PPARs (22, 54, 254 55) . The inhibition of LPCAT3 enhances insulin signaling at the level of IR to improve skeletal 255 muscle insulin sensitivity. We believe that the insulin-sensitizing effect of Lands cycle inhibition 256 is mediated by its effect on the plasma membrane lipid organization ( Figure 6 ). Consistent with 257 this notion, LPCAT3 deletion and/or CI-976 treatment was sufficient to alter membrane 258 phospholipid packing, GM1-microdomain clustering, cav3 content and lipid composition of 259 detergent-resistant and -soluble membranes. Furthermore, disruption of cholesterol-rich 260 microdomains was sufficient to eliminate the insulin-sensitizing effect of LPCAT3 inhibition. 261
Interventions that interfere with the plasma membrane organization would be predicted to have 262 effects on other cellular events, but the deletion of LPCAT3 did not appear to have an overly 263 adverse effect on skeletal muscle, including mass, fiber-type or force-generating capacity. It 
Human Subjects 279
All participants were prescreened to be free of any known metabolic diseases or heart 280 conditions, nontobacco users, not taking any medications known to alter metabolism, and 281 sedentary. Six lean subjects without diabetes (LN: BMI < 25 kg/m 2 ) and six subjects with severe 282 obesity (OB: BMI > 40 kg/m 2 ) were studied (all Caucasian females). The subjects were 283 instructed not to exercise for approximately 48h before the muscle biopsy. A fasting blood 284 sample (glucose and insulin) and muscle biopsy from the vastus lateralis were collected. A 285 portion of the biopsy sample was frozen immediately, and another portion was used to isolate 286 primary muscle cells. 287
288
Cell Culture 289
Primary human skeletal muscle cells (HSkMC) were isolated from fresh muscle biopsies as 290 previously described (15, 56) . HSkMC were cultured in growth media containing low glucose 291 DMEM, 10x FBS, 0.5 mg/mL BSA, 0.5 mg/mL fetuin, 10 ng/mL human EGF, 1 µM 292 dexamethasone, and 0.1% penicillin-streptomycin. HSkMC were differentiated in low glucose 293 DMEM, 2% horse serum, 0.5 mg/mL BSA, 0.5 mg/mL fetuin, and 0.1% penicillin-streptomycin. 294 with methyl-beta-cyclodextrin cells were incubated with 10 mM (1320 g/mole) for 1 hour directly 302 dissolved into media. Prior to all experiments cells were serum-starved for 3 hours in low 303 glucose DMEM containing 1% BSA and 0.1% penicillin-streptomycin. 304 305
Quantitative-RT-PCR 306
Samples were homogenized in TRIzol reagent (Life Technologies, Grand Island, NY) to extract 307 total RNA. 1 μg RNA was reverse transcribed using IScript TM cDNA synthesis kit (Biorad, 308
Hercules, CA). RT-PCR was performed with the Viia TM 7 Real-Time PCR System (Life 309
Technologies, Grand Island, NY) using SYBR® Green reagent (Life Technologies, Grand 310 Island, NY). All data were normalized to ribosomal L32 gene expression and primer sequences 311 are provided (Extended Data Table 2) . 312 313
Mass Spectrometry 314
Global lipidomic analyses for LN and OB HSkMC were performed at the Mass Spectrometry 315
Resource at the Washington University School of Medicine (15). Extracted lipids with internal 316 standards were analyzed with a Thermo Vantage triple-quadrupole mass spectrometer or a 317
Thermo Trace GC Ultra mass spectrometer. Targeted lipidomic analyses for C2C12 myotubes 318 and mouse skeletal muscles were conducted in the Metabolomics Core at the University of Utah 319 (57-59). Extracted lipids with internal standards were analyzed with an Agilent triple-quadrupole 320 mass spectrometer. The quantity of each lipid species was normalized to total lipid content for 321 DRM/DSM experiments or to the total protein content for all others. The phospholipid saturation 322 index was quantified by multiplying the relative abundance of each phospholipid species by the 323 total number of double bonds in the acyl chains of that species. 324 325
Merocyanine 540 326
Merocyanine 540 (MC540) measurements were taken as previously described (60). In short, 327 skeletal muscle cells (C2C12 and HSkMC) were fully differentiated and 2 million were used for 328 measurements. Cells were washed with Hanks Balanced Salt Solution (HBSS; Gibco 329 14025092) prior to re-suspension in a cuvette with HBSS. MC540 in DMSO was added at a final 330 concentration of 0.2 µM and after a 10-minute dark incubation, an emission scan was performed 331 ranging from 550-750 nm with fluorescence excitation set at 540 nm on a PTI QuantaMaster 332 6000 Fluorimeter. 
Glycogen Synthesis 360
The glycogen synthesis rate was quantified as previously described (61, 62) . Briefly, cells were 361 incubated in media containing D-[U-14 C] glucose with (12 nM) or without insulin for 2h at 37 °C. 362
Cells were then washed with ice-cold PBS and homogenized for 1h with 0.05% SDS. Part of the 363 lysate was used for a protein assay and the other was combined with 2mg carrier glycogen and 364 incubated at 100 °C for 1h. Ice cold ethanol (100%) was added to the boiled samples prior to 365 overnight rocking at 4 °C. Samples were then centrifuged at 11,000 xG for 15 min at 4 °C to 366 pellet glycogen. Pellets were re-suspended in de-ionized H2O and glycogen synthesis was 367 calculated with liquid scintillation. 368 369
Generation of LPCAT3 Skeletal Muscle-Specific Knock Out Mice 370
Conditional LPCAT3 knock out (LPCAT3cKO+/+) mice were previously generated by flanking 371 exon3 of the Lpcat3 gene with loxP sites (25). LPCAT3cKO+/+ mice were then crossed with Prior to all terminal experiments and tissue harvesting, mice were given an intraperitoneal 378 injection of 80 mg/kg ketamine and 10 mg/kg xylazine. 379
Glucose Tolerance Test 381
Intra-peritoneal glucose tolerance tests were performed by injecting 1 mg glucose/g body mass. 382
Mice were fasted for 4 hours prior to glucose injection. Blood glucose was measured prior to 383 glucose injection and 15, 30, 60, and 120 minutes post-injection via tail bleed with a handheld 384 glucometer (Bayer Contour 7151H). In a separate set of experiments, mice were injected with 1 385 mg glucose/g body mass and blood was taken from the facial vein at the 30-minute time point 386 for insulin quantification. 387 388
Serum Insulin and Glucose Quantification 389
Blood was collected from the facial vein either prior to anesthesia or at the 30-minute time point 390 of the glucose tolerance test. Blood was then placed at room temperature for 20 minutes to 391 allow for clotting before centrifugation at 2,000 xG for 10 minutes at 4°C. The supernatant 392 (serum) was placed in a separate tube and stored at -80 °C until analysis. 393
Serum glucose was quantified using a colorimetric assay. A glucose standard curve was 394 generated (Millipore Sigma, G6918) and serum samples were mixed with a PGO enzyme 395 (Millipore Sigma, P7119) and colorimetric substrate (Millipore Sigma, F5803) and measured at 396 OD450 on a plate reader. Serum insulin was quantified using an insulin mouse serum kit 397 (CisBio, 62IN3PEF) using Fluorescence Resonance Energy Transfer on a plate reader 398 (ThermoFisher, Varioskan LUX). 399
[ 3 H]2-Deoxy-D-Glucose Uptake 401
Ex vivo glucose uptake was measured in the soleus muscle as previously described (63, 64). In 402 brief, soleus muscles were dissected and placed in a recovery buffer (KHB with 0.1% BSA, 8 403 mM glucose, and 2 mM mannitol) at 37 °C for 10 minutes. After incubation in recovery buffer, 404 muscles were moved to pre-incubation buffer (KHB with 0.1% BSA, 2 mM sodium pyruvate, and 405 6 mM mannitol) ± 200 µU/mL insulin for 15 minutes. After pre-incubation muscles were placed 406 in incubation buffer (KHB with 0.1% BSA, 9 mM [ 14 C]mannitol, 1 mM [ 3 H]2-deoxyglucose) ± 200 407 µU/mL insulin for 15 minutes. Contralateral muscles were used for basal or insulin-stimulated 408 measurements. After incubation muscles were blotted dry on ice-cold filter paper, snap-frozen, 409
and stored at -80 °C until analyzed with liquid scintillation counting. 410 411
Muscle Force Generation 412
Force generating properties of extensor digitorum longus (EDL) muscles were measured as 413 previously described (65). Briefly, EDL muscles were sutured at each tendon and muscles were 414 Invitrogen: A21426), respectively. Negatively stained fibers were considered myosin heavy 429 chain IIx (MHC IIx). After staining, slides were coverslipped with mounting media (Vector: H-430 1000). Stained slides were imaged with a fully automated wide-field light microscope (Nikon, 431 Nikon Corp.; Tokyo, Japan) with a 10X objective lens. Images were captured using high 432 sensitivity Andor Clara CCD (Belfast, UK). 433
434
GM-1 Labeling and Imaging 435
GM-1 clusters were labeled using a Vybrant ® Alexa Fluor ® 488 Lipid Raft Labeling Kit 436 (ThermoFisher Scientific: V34404) as previously described (69). Briefly, 2 million myotubes 437 were incubated 1mL in ice-cold starvation media with 0.8µg/mL fluorescent cholera toxin subunit 438 B conjugate (CT-B) for 10 minutes. CT-B conjugates were then cross-linked with an anti-CT-B 439 antibody (1:200) in ice-cold starvation media for 15 minutes. Cells were fixed for 1 h at 4 °C in 440
ice-cold 4% paraformaldehyde in PBS in dark. Between each step, cells were washed 2x in ice-441 cold PBS. Cells were imaged on an Olympus FV1000 confocal microscope (2.5x, HV:600, 442 offset: 30). Images were processed using NIH ImageJ. All images were background subtracted 443 with a rolling ball radius of 50 pixels. Images were blindly scored by S.R.S and K.F. as exhibiting 444 clustering of microdomains or non-clustering. Images were then subjected to color thresholding 445 using the Otsu method (70, 71) (designed for thresholding images for cluster analyses) and 446 made binary. A particle analysis of all particles that were >0.1µm 2 was performed to determine 447 the average cluster size for each cell that was imaged (72). For each experiment, 35-50 cells 448 per group were analyzed and the median was taken as a representative of that experiment. 449 450
Detergent-Resistant Membrane Isolation 451
Detergent-resistant membranes (DRM) and detergent-soluble membranes (DSM) were isolated 452 as previously described (72). Briefly, 2x15 cm plates of cells were scraped in ice-cold PBS and 453 then pelleted. Cells were re-suspended in 1mL of cold homogenization buffer (Mes-buffered 454 saline [MBS], 1% Triton-X wt/v, and protease and phosphatase inhibitor) and passed through a 455 23-gauge needle 6 times before incubating at 4 °C for 30 minutes. MBS was added to the 456 homogenate until a volume of 2.5 mL was reached then mixed with 2.5 mL of 90% sucrose in 457 MBS and 4mL of this mixture was added to an ultracentrifuge tube (Beckman Coulter 344061). 458
A sucrose gradient was generated by adding 4 mL 35% sucrose followed by 4mL of 5% 459 sucrose. Samples were then centrifuged at 100,000 xG at 4 °C for 20 hours in a swinging 460 bucket rotor (Beckman L8-M Ultracentrifuge, SW28 Rotor). Proteomics core is supported by S10 OD016232, S10 OD021505, and U54 DK110858. The 492
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